To stimulate original research in pursuit of new treatments — and eventually a cure — for polycythemia vera, essential thrombocythemia, and myelofibrosis (myeloproliferative neoplasms).
The Mpn Research Foundation centers its giving on original research aimed at new treatments and, ultimately, a cure for myeloproliferative neoplasms, including polycythemia vera, essential thrombocythemia, and myelofibrosis. Its recent grants show a consistent pattern of $100,000 research awards, with larger $200,000 grants also appearing in 2023. That mix points to a foundation structured around project-specific biomedical funding rather than broad operating support. The foundation’s recent grant list is anchored by awards to major research institutions such as Weill Cornell Medicine and Dana-Farber Cancer Institute. It also funds work at New York University Grossman School of Medicine, Yale University School of Medicine, University of Chicago, City of Hope National Medical Center, Boston University School of Medicine, and University of Minnesota Twin Cities. Across these grants, the focus stays tightly on MPN research rather than a wider cancer portfolio. Its stated research priorities include early detection, thrombotic and cardiovascular risk, epigenomic and environmental factors, new mechanisms of action, and quality of life research. Named funds such as the Susan Ann Protter Research Fund and the Robert B. Rosen Memorial Fund suggest additional targeted support within the same disease area.
A core theme in The Mpn Research Foundation’s grantmaking is translational research on MPN disease biology. The foundation supports studies on early detection, thrombotic and cardiovascular risk, epigenomic and environmental factors, and new mechanisms of action through its research grant programs. Those priorities are reflected in awards such as $100,000 to Yale University School of Medicine for MPN research and $100,000 to City of Hope National Medical Center for the same purpose. The foundation also backs work on progression and biomarkers. Its Susan Ann Protter Research Fund is described as supporting investigator-led research relevant to MPN progression and biomarkers, while the Robert B. Rosen Memorial Fund supports MPN research broadly and investigator-initiated projects. Recent grants to Msk Tissue Bank and Boston University School of Medicine fit that research-oriented pattern. Quality of life research is also part of the agenda, alongside studies on polycythemia vera, essential thrombocythemia, and myelofibrosis. That scope keeps the foundation focused on disease-specific projects rather than general hematology funding.
$300K
$8M
$3.6M
$3.8M
Most grants fall between $100K and $100K, with a median of $100K.
25th Percentile
$100K
Median
$100K
75th Percentile
$100K
About 8% of grants go to recipients in MA.
KAPILA VIGES
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
The Mpn Research Foundation’s typical grant size is $100,000, with p25, median, and p75 all at that level. Recent awards also include $200,000 grants, indicating some larger project support alongside the standard amount. The foundation operates as a research funder rather than an individual-support organization, and it does not make program-related investments. Its grantmaking appears recurring rather than one-off: the same institutions show up across multiple recent years, including Dana-Farber Cancer Institute, New York University Grossman School of Medicine, Yale University School of Medicine, University of Chicago, City of Hope National Medical Center, Boston University School of Medicine, and University of Minnesota Twin Cities. The active programs also show an unsolicited application pathway through an online grant process.
Grantmaking is national in scope, and every recent grant listed went to a U.S. recipient. Massachusetts appears as the top state by grant count, while Illinois receives 10% of grants. Recent awards land in several research hubs, including Boston, New York City, New Haven, Chicago, Duarte, Minneapolis, St. Louis, Memphis, and Salt Lake City. The recipient distribution is concentrated in U.S. academic medical centers rather than spread across community organizations.
It funds original research on myeloproliferative neoplasms, especially polycythemia vera, essential thrombocythemia, and myelofibrosis. The stated priorities include early detection, thrombotic and cardiovascular risk, epigenomic and environmental factors, new mechanisms of action, quality of life research, and work on disease progression and biomarkers.
Its typical grant size is $100,000, and the p25, median, and p75 are all $100,000. Recent awards also include $200,000 grants, showing that some projects receive larger support than the standard amount.
Yes. Several active programs are marked as accepting unsolicited applications, including the MPNRF Research Grants, MPNRF General Research Grants, the Susan Ann Protter Research Fund, the Robert B. Rosen Memorial Fund, and the MPN Challenge™ Grant Program. The foundation also lists an online grant application process.
Its stated geographic scope is national, and the recent grants listed all went to U.S. recipients. Active programs also reference U.S., Canada, Australia, and global geographies depending on the program.
Two named funds are identified: the Susan Ann Protter Research Fund and the Robert B. Rosen Memorial Fund. The Protter fund supports investigator-led research relevant to MPN progression and biomarkers, while the Rosen fund supports MPN research broadly and investigator-initiated projects.
2026
Source: IRS Form 990-PF, fiscal year 2026.
Current and upcoming funding from Mpn Research Foundation that your nonprofit may be able to apply for.
Who can apply: At this time, only patients living in the United States who are 18 or older and have ever been diagnosed with an MPN may enroll. De-identified data is shared only with pre-screened, approved MPN research projects and researchers.
Who can apply: Scientists interested in access to MPN patient samples can submit a proposal to the MPN-RC Tissue Bank review committee. Requests are evaluated based on scientific merit, feasibility, and alignment with the Tissue Bank’s mission.
Track these deadlines, get reminders, and see how well your nonprofit fits — free with a Kindora account.
Create a free accountDeadlines and eligibility are summarized from public sources and may change — always confirm the details on the funder's official application page before applying.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| UNIVERSITY OF NORTH CAROLINA | CHAPEL HILL, NC | $100,000 | 2026 | MPN RESEARCH |
| JOHNS HOPKINS UNIVERSITY | BALTIMORE, MD | $100,000 | 2026 | MPN RESEARCH |
| BRIGHAM AND WOMEN'S HOSPITAL HEMATOLOGY | BOSTON, MA | $99,634 | 2026 | MPN RESEARCH |
| UNIVERSITY OF NORTH CAROLINA | CHAPEL HILL, NC | $100,000 | 2025 | MPN RESEARCH |
| JOHNS HOPKINS UNIVERSITY | BALTIMORE, MD | $100,000 | 2025 | MPN RESEARCH |
| BRIGHAM AND WOMEN'S HOSPITAL HEMATOLOGY | BOSTON, MA | $99,634 | 2025 | MPN RESEARCH |
| UNIVERSITY OF CHICAGO | CHICAGO, IL | $100,000 | 2024 | MPN RESEARCH |
| CITY OF HOPE NATIONAL MEDICAL CENTER | DUARTE, CA | $100,000 | 2024 | MPN RESEARCH |
| BOSTON UNIVERSITY SCHOOL OF MEDICINE | BOSTON, MA | $100,000 | 2024 | MPN RESEARCH |
| MSK TISSUE BANK | NEW YORK, NY | $100,000 | 2024 | MPN RESEARCH |
| UNIVERSITY OF MINNESOTA TWIN CITIES | MINNEAPOLIS, MN | $100,000 | 2024 | MPN RESEARCH |
| NEW YORK UNIVERSITY GROSSMAN SCHOOL OF MEDICINE | NEW YORK, NY | $100,000 | 2024 | MPN RESEARCH |
| DANA FARBER CANCER INSTITUTE | BOSTON, MA | $100,000 | 2024 | MPN RESEARCH |
| YALE UNIVERSITY SCHOOL OF MEDICINE | NEW HAVEN, CT | $100,000 | 2024 | MPN RESEARCH |
| ICHAN SCHOOL OF MEDICINE | NEW YORK, NY | $200,000 | 2023 | MPN RESEARCH |
| WEILL CORNELL MEDICINE | NEW YORK, NY | $200,000 | 2023 | MPN RESEARCH |
| DANA FARBER CANCER INSTITUTE | BOSTON, MA | $200,000 | 2023 | MPN RESEARCH |
| UNIVERSITY OF MINNESOTA TWIN CITIES | MINNEAPOLIS, MN | $100,000 | 2023 | MPN RESEARCH |
| UNIVERSITY OF CHICAGO | CHICAGO, IL | $100,000 | 2023 | MPN RESEARCH |
| CITY OF HOPE NATIONAL MEDICAL CENTER | DUARTE, CA | $100,000 | 2023 | MPN RESEARCH |
| STANFORD UNIVERSITY | REDWOOD CITY, CA | $100,000 | 2023 | MPN RESEARCH |
| ST JUDE CHILDREN'S RESEARCH HOSPITAL | MEMPHIS, TN | $100,000 | 2023 | MPN RESEARCH |
| NEW YORK UNIVERSITY GROSSMAN SCHOOL OF MEDICINE | NEW YORK, NY | $100,000 | 2023 | MPN RESEARCH |
| YALE UNIVERSITY SCHOOL OF MEDICINE | NEW HAVEN, CT | $100,000 | 2023 | MPN RESEARCH |
| THE UNIVERSITY OF UTAH | SALT LAKE CITY, UT | $100,000 | 2023 | MPN RESEARCH |
| THE WASHINGTON UNIVERSITY | ST LOUIS, MO | $100,000 | 2023 | MPN RESEARCH |
| BOSTON UNIVERSITY SCHOOL OF MEDICINE | BOSTON, MA | $100,000 | 2023 | MPN RESEARCH |
UNIVERSITY OF NORTH CAROLINA
$100,000MPN RESEARCH
BRIGHAM AND WOMEN'S HOSPITAL HEMATOLOGY
$99,634MPN RESEARCH
UNIVERSITY OF NORTH CAROLINA
$100,000MPN RESEARCH
BRIGHAM AND WOMEN'S HOSPITAL HEMATOLOGY
$99,634MPN RESEARCH
MSK TISSUE BANK
$100,000MPN RESEARCH
UNIVERSITY OF MINNESOTA TWIN CITIES
$100,000MPN RESEARCH
WEILL CORNELL MEDICINE
$200,000MPN RESEARCH
UNIVERSITY OF MINNESOTA TWIN CITIES
$100,000MPN RESEARCH
THE UNIVERSITY OF UTAH
$100,000MPN RESEARCH